300 IR Sublingual Immunotherapy Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 300 IR Sublingual Immunotherapy Tablet, covering 2016-05-25 to 2016-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets [Phase 3]